A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Venous Leg Ulcers
Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
This is a Phase II, randomized, controlled, two-center pilot study designed to assess the
safety and efficacy of MEBO in the treatment of 14 subjects with VLUs. Subjects meeting entry
criteria will be randomly assigned in a 1:1 ratio for up to 8 weeks of treatment with either
MEBO or SOC (7 subjects per treatment arm).